Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment

被引:36
作者
Fomchenko, Elena I.
Holland, Eric C.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg Neurosurg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Canc Biol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
关键词
D O I
10.1016/j.nec.2006.10.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Platelet-derived growth factor (PDGF) is a growth factor family of ligands and receptors known to activate phosphatidylinositol 3-kinase, mitogen-activated protein kinase, Jak family kinase, Src family kinase, and phospholipase C gamma signal transduction pathways, some of which have been causally linked to glioma formation. Extensive involvement of PDGF in development and its implication in a variety of pathologic conditions, including gliomagenesis, are mediated not only by autocrine effects but by paracrine effects. Many researchers view brain tumors as clonal entities derived from the cancer stem cell; however, recent documentation of the importance of the tumor microenvironment for glioma initiation and progression as well as the ability of neural stem or progenitor cells to migrate toward the sites of injury or tumor formation reveals additional complexities in brain tumorigenesis. Paracrine effects of PDGF in animal models of gliomagenesis, continued adult neurogenesis capable of increasing in response to brain injury, and the growth factor-rich environment of brain tumors suggest that recruitment may play a role in gliomagenesis. In this view, glioma formation involves recruitment of cells from the adjacent brain and possibly other sites.
引用
收藏
页码:39 / +
页数:21
相关论文
共 179 条
[61]   Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents [J].
Gritti, A ;
Bonfanti, L ;
Doetsch, F ;
Caille, I ;
Alvarez-Buylla, A ;
Lim, DA ;
Galli, R ;
Verdugo, JMG ;
Herrera, DG ;
Vescovi, AL .
JOURNAL OF NEUROSCIENCE, 2002, 22 (02) :437-445
[62]   Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways [J].
Guan, QH ;
Pei, DS ;
Zong, YY ;
Xu, TL ;
Zhang, GY .
NEUROSCIENCE, 2006, 139 (02) :609-627
[63]   Platelet-derived growth factor-b enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment [J].
Guo, P ;
Hu, B ;
Gu, WS ;
Xu, L ;
Wang, DG ;
Huang, HJS ;
Cavenee, WK ;
Cheng, SY .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1083-1093
[64]   The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat central nervous system [J].
Hamada, T ;
Ui-Tei, K ;
Imaki, J ;
Takahashi, F ;
Onodera, H ;
Mishima, T ;
Miyata, Y .
MECHANISMS OF DEVELOPMENT, 2002, 112 (1-2) :161-164
[65]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[66]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[67]  
HAYASHI N, 1991, CANCER RES, V51, P4924
[68]  
HEIDARAN MA, 1993, J BIOL CHEM, V268, P9287
[69]   High interstitial fluid pressure -: An obstacle in cancer therapy [J].
Heldin, CH ;
Rubin, K ;
Pietras, K ;
Östman, A .
NATURE REVIEWS CANCER, 2004, 4 (10) :806-813
[70]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316